Nature Reviews' clinical content is written by internationally renowned clinical academics and researchers and targeted towards readers in the medical sciences, from postgraduate level upwards. While intended to be read by practicing doctors, researchers and academics within a specialty, we aim to make all our articles accessible to readers working in any medical discipline.In-depth Reviews present authoritative, up-to-date information on a topic, placing it in the context of a field's history and development. Topical discussion and opinions are proffered in Perspectives and News & Views articles, and in the Research Highlights section we filter primary research from a range of specialty and general medical journals.
《自然评论》的临床内容由国际知名的临床学者和研究人员撰写，面向医学科学领域的读者，从研究生水平向上。我们的目标读者是专业领域内的执业医生、研究人员和学者，但我们的目标是让所有从事医学学科的读者都能阅读我们的文章。深入评论提供关于某个主题的权威、最新信息，并将其置于该领域的历史和发展背景下。主题讨论和观点在观点和新闻与观点文章中提供，在研究亮点部分，我们从一系列专业和综合医学期刊中筛选主要研究。
Ageing as a risk factor for neurodegenerative disease
来源期刊：Nature Reviews NeurologyDOI：10.1038/s41582-019-0244-7
Immunoneuropsychiatry — novel perspectives on brain disorders
来源期刊：Nature Reviews NeurologyDOI：10.1038/s41582-019-0174-4
Genetic and molecular epidemiology of adult diffuse glioma
来源期刊：Nature Reviews NeurologyDOI：10.1038/s41582-019-0220-2
Therapeutic developments for Duchenne muscular dystrophy
来源期刊：Nature Reviews NeurologyDOI：10.1038/s41582-019-0203-3
Narcolepsy — clinical spectrum, aetiopathophysiology, diagnosis and treatment
来源期刊：Nature Reviews NeurologyDOI：10.1038/s41582-019-0226-9
The pro-remyelination properties of microglia in the central nervous system
来源期刊：Nature Reviews NeurologyDOI：10.1038/s41582-019-0184-2
Axonal transport and neurological disease
来源期刊：Nature Reviews NeurologyDOI：10.1038/s41582-019-0257-2
Epidemiology and treatment of multiple sclerosis in elderly populations
来源期刊：Nature Reviews NeurologyDOI：10.1038/s41582-019-0183-3
Reaching an evidence-based prognosis for personalized treatment of multiple sclerosis
来源期刊：Nature Reviews NeurologyDOI：10.1038/s41582-019-0170-8
Post-traumatic headache: epidemiology and pathophysiological insights
来源期刊：Nature Reviews NeurologyDOI：10.1038/s41582-019-0243-8
Questions EMERGE as Biogen claims aducanumab turnaround
来源期刊：Nature Reviews NeurologyDOI：10.1038/s41582-019-0295-9
The metabolic face of migraine — from pathophysiology to treatment
来源期刊：Nature Reviews NeurologyDOI：10.1038/s41582-019-0255-4
The neural and neurocomputational bases of recovery from post-stroke aphasia
来源期刊：Nature Reviews NeurologyDOI：10.1038/s41582-019-0282-1
When encephalitogenic T cells collaborate with microglia in multiple sclerosis
来源期刊：Nature Reviews NeurologyDOI：10.1038/s41582-019-0253-6
Parkinson disease and growth factors — is GDNF good enough?
来源期刊：Nature Reviews NeurologyDOI：10.1038/s41582-019-0180-6
The promise of technology in the future of dementia care
来源期刊：Nature Reviews NeurologyDOI：10.1038/s41582-019-0188-y
Towards artificial intelligence for clinical stroke care
来源期刊：Nature Reviews NeurologyDOI：10.1038/s41582-019-0287-9
Does neoadjuvant anti-PD1 therapy improve glioblastoma outcome?
来源期刊：Nature Reviews NeurologyDOI：10.1038/s41582-019-0178-0
Getting closer to a cure for migraine
来源期刊：Nature Reviews NeurologyDOI：10.1038/s41582-019-0134-z
CGRP antibodies for migraine prevention — new kids on the block
来源期刊：Nature Reviews NeurologyDOI：10.1038/s41582-019-0139-7
Refining the understanding of typical Alzheimer disease
来源期刊：Nature Reviews NeurologyDOI：10.1038/s41582-019-0259-0
Neurofilament light chain — new potential for prediction and prognosis
来源期刊：Nature Reviews NeurologyDOI：10.1038/s41582-019-0265-2
Targeting progression in multiple sclerosis — an update
来源期刊：Nature Reviews NeurologyDOI：10.1038/s41582-018-0127-3
Stroke prediction and the future of prognosis research
来源期刊：Nature Reviews NeurologyDOI：10.1038/s41582-019-0181-5
Severe impairment of motor function in congenital Zika syndrome
来源期刊：Nature Reviews NeurologyDOI：10.1038/s41582-019-0191-3
Glioma progression through synaptic activity
来源期刊：Nature Reviews NeurologyDOI：10.1038/s41582-019-0290-1
The complexity of neuroinflammation at single-cell resolution
来源期刊：Nature Reviews NeurologyDOI：10.1038/s41582-019-0165-5
Naturally occurring antibodies target Parkinson disease pathology
来源期刊：Nature Reviews NeurologyDOI：10.1038/s41582-019-0167-3
T helper cells implicated in early Huntington disease
来源期刊：Nature Reviews NeurologyDOI：10.1038/s41582-019-0297-7
Ultrasound success removes barriers to targeted drug delivery in amyotrophic lateral sclerosis
来源期刊：Nature Reviews NeurologyDOI：10.1038/s41582-019-0276-z
Genetics trumps a healthy lifestyle in the risk of dementia
来源期刊：Nature Reviews NeurologyDOI：10.1038/s41582-019-0266-1
Phase II trial of evobrutinib in multiple sclerosis
来源期刊：Nature Reviews NeurologyDOI：10.1038/s41582-019-0212-2
Iron deposition in periaqueductal grey matter as a biomarker of chronic migraine
来源期刊：Nature Reviews NeurologyDOI：10.1038/s41582-019-0151-y
Intrathecal immunoglobulin M predicts conversion from CIS to MS
来源期刊：Nature Reviews NeurologyDOI：10.1038/s41582-019-0272-3
Stroke trial drug is effective in Alzheimer disease mouse model
来源期刊：Nature Reviews NeurologyDOI：10.1038/s41582-019-0141-0
Reply to ‘Neuropathological progression of clinical Parkinson disease subtypes’
来源期刊：Nature Reviews NeurologyDOI：10.1038/s41582-019-0198-9
High-salt diet promotes Alzheimer disease-like changes
来源期刊：Nature Reviews NeurologyDOI：10.1038/s41582-019-0289-7
Perivascular spaces are associated with cognition
来源期刊：Nature Reviews NeurologyDOI：10.1038/s41582-019-0169-1
Different clinical profiles in Huntington disease show distinct patterns of brain alterations
来源期刊：Nature Reviews NeurologyDOI：10.1038/s41582-019-0237-6
Antibiotic use might increase risk of ALS
来源期刊：Nature Reviews NeurologyDOI：10.1038/s41582-019-0238-5
Restoration of cellular activity after decapitation
来源期刊：Nature Reviews NeurologyDOI：10.1038/s41582-019-0209-x
Exploring vascular Aβ pathology using microvessel extracts from frozen human brain samples
来源期刊：Nature Reviews NeurologyDOI：10.1038/s41582-019-0152-x
Author Correction: Progress in multiple sclerosis — from diagnosis to therapy
来源期刊：Nature Reviews NeurologyDOI：10.1038/s41582-019-0179-z
Gene therapy is effective for CMT in mice
来源期刊：Nature Reviews NeurologyDOI：10.1038/s41582-019-0193-1
Oligonucleotide designed for ultimate personalized treatment
来源期刊：Nature Reviews NeurologyDOI：10.1038/s41582-019-0286-x
Prodromal frontotemporal dementia associated with changes in ventricular volume
来源期刊：Nature Reviews NeurologyDOI：10.1038/s41582-019-0277-y
Calcitonin gene-related peptide — beyond migraine prophylaxis
来源期刊：Nature Reviews NeurologyDOI：10.1038/s41582-019-0258-1
Ultrasensitive assay raises hope of plasma PD marker
来源期刊：Nature Reviews NeurologyDOI：10.1038/s41582-019-0159-3
Alternative gene therapy target identified in spinal muscular atrophy mice
来源期刊：Nature Reviews NeurologyDOI：10.1038/s41582-019-0262-5
Brain–machine interaction improves mobility
来源期刊：Nature Reviews NeurologyDOI：10.1038/s41582-019-0285-y
